Profit before tax (PBT) rose 31.8% YoY to Rs 83.61 crore in Q2 FY26.

Total expenses rose 11.79% to Rs 2342.52 crore in Q2 FY26 compared with Rs 2095.41 crore posted in corresponding quarter last year. Cost of material consumed stood at Rs 660.85 crore (up 13.11% YoY), employee benefit expenses was at Rs 32.11 crore (up 6.04% YoY), finance cost stood at Rs 49.28 crore (up 23.48% YoY) during the quarter.

In Q2 FY26, revenue from Bio Fuel segment stood at Rs 422.81 crore, up 62.89% YoY, revenue from potable spirits jumped 14.04% YoY to Rs 1,657.82 crore,. However, the Ennature Biopharma segment reported a decline of 28.73% YoY to Rs 43.44 crore and revenue from bio-based specialties and performance chemicals business dropped 21.95% YoY to Rs 288.33 crore.

India Glycols (IGL) manufactures green technology-based bulk, specialty and performance chemicals and natural gums, spirits, industrial gases, sugar and nutraceuticals. IGL operates under three broad segments: bio-based specialities & performance chemicals (BSPC), potable spirits (PS) and ennature biopharma (EB).

The scrip touched an all-time high at Rs 1,134.60 in intraday today.